Allez Health has raised $60 million in a Series A for its continuous glucose monitoring (CGM) biosensor platform for connected digital health platforms.
BoydSense's new prototype allows diabetics and pre-diabetics to check their blood glucose levels by breathing into a device.
Sign Up to Our Newsletter
